TG Therapeutics, Inc. (TGTX) operating KPIs
TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3020% below fair value
$61.18+3.10 (+5.34%)
Close on Oct 30, 2026Market cap $9.36BP/E 22.3Yield –
KPIs
Operating metrics that drive TG Therapeutics's business
Coming soon
This tab will track the numbers specific to TG Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.